Current challenges and emerging opportunities of chimeric antigen receptor-engineered cell immunotherapy
{{output}}
Chimeric antigen receptor (CAR) engineered cellular immunotherapy offers the potential for precise targeting and elimination of tumor cells, providing a tailored approach to cancer treatment. CAR-T cells demonstrate significant anti-tumor activity among these ... ...
